Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

about

Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.Construction of a stable w/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine.

P2860

Q38851217-130D40B7-C769-4211-96DC-170DD96FC908 Q40691918-F57B5844-83E3-41F2-BFAB-217F18446076

P2860

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

Item

http://www.wikidata.org/entity/Q38252451

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

@en

type

Item

label

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

@en

prefLabel

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

@en

P1476

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

@en

P2093

Yimei Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

Toll-like receptors

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine.

International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants.

Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells.

P304

1377-1385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/14760584.2014.963562

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25234962

http://www.w3.org/2001/XMLSchema#string

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

about

P2860

P2860

Adjuvants for foot-and-mouth disease virus vaccines: recent progress.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698